These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
61 related items for PubMed ID: 2244279
21. Management for patients with advanced T4 epidermoid carcinoma of the esophagus. Wang LS, Chi KH, Hu MH, Fahn HJ, Huang MH. J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396 [Abstract] [Full Text] [Related]
23. [Split-course concomitant radiochemotherapy plus surgery vs. surgery alone in squamous cell carcinoma of the esophagus. A non-randomized retrospective study of 184 patients]. Malhaire JP, Lozac'h P, Simon H, Labat JP, Topart P, Lucas B, Metges JP, Lamezec B. Bull Cancer; 1997 Apr; 84(4):357-67. PubMed ID: 9238158 [Abstract] [Full Text] [Related]
24. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease. El Nakadi I, Van Laethem JL, Houben JJ, Gay F, Closset J, Van Houtte P, Danhier S, Limbosch JM, Lambilliotte JP, Gelin M. World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037 [Abstract] [Full Text] [Related]
25. Surgical treatment of advanced carcinoma of the esophagus. Abe S, Tachibana M, Shimokawa T, Shiraishi M, Nakamura T. Surg Gynecol Obstet; 1989 Feb; 168(2):115-20. PubMed ID: 2463681 [Abstract] [Full Text] [Related]
26. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Gotoh M, Takiuchi H, Kawabe S, Ohta S, Kii T, Kuwakado S, Katsu K. Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077 [Abstract] [Full Text] [Related]
27. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Kim MK, Kim SB, Ahn JH, Kim YH, Kim JH, Jung HY, Lee GH, Choi KD, Song HY, Shin JH, Cho KJ, Ryu JS, Park SI. Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):725-34. PubMed ID: 18164836 [Abstract] [Full Text] [Related]
28. [Cox regression analysis of the prognostic factors of unresectable esophageal carcinoma after stenting]. Fu JH, Rong TH, Li XD, Ma GW, Hu Y, Min HQ. Ai Zheng; 2003 Jan 01; 22(1):91-4. PubMed ID: 12561445 [Abstract] [Full Text] [Related]
29. Complete eradication of squamous cell carcinoma of the esophagus with combined chemotherapy and radiotherapy. Steiger Z, Franklin R, Wilson RF, Leichman L, Asfaw I, Vaishanpayan G, Rosenberg JC, Loh JJ, Dindogru A, Seydel H, Hoschner J, Miller P, Knechtges T, Vaitkevicius V. Am Surg; 1981 Mar 01; 47(3):95-8. PubMed ID: 6163382 [Abstract] [Full Text] [Related]
30. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA, Duhaylongsod FG. J Thorac Cardiovasc Surg; 1993 Apr 01; 105(4):749-55; discussion 755-6. PubMed ID: 8469009 [Abstract] [Full Text] [Related]
31. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. Chen G, Wang Z, Liu XY, Zhang MY, Liu FY. Eur J Cardiothorac Surg; 2009 Jan 01; 35(1):1-7. PubMed ID: 18926712 [Abstract] [Full Text] [Related]
32. [A preliminary study of surgical therapy and combined therapy for cervical esophageal carcinoma]. Qi Y, Tu G, Tang P. Zhonghua Wai Ke Za Zhi; 1995 Mar 01; 33(3):176-8. PubMed ID: 7555390 [Abstract] [Full Text] [Related]
33. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179 [Abstract] [Full Text] [Related]
34. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. Kulke MH, Odze RD, Mueller JD, Wang H, Redston M, Bertagnolli MM. J Thorac Cardiovasc Surg; 2004 Jun 01; 127(6):1579-86. PubMed ID: 15173710 [Abstract] [Full Text] [Related]
35. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance. Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2301-7. PubMed ID: 9815628 [Abstract] [Full Text] [Related]
36. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer. Babu M, Mathur M, Gupta SD, Chattopadhyay TK. Trop Gastroenterol; 1996 Dec 01; 17(1):57-60. PubMed ID: 8693588 [Abstract] [Full Text] [Related]
37. [Hyperthermia combined with chemotherapy and irradiation for esophageal carcinoma]. Sugimachi K, Matsufuji H, Kai H, Kitamura M, Maekawa S. Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 2):1360-5. PubMed ID: 3729455 [Abstract] [Full Text] [Related]
38. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus]. Han JQ, Liu Q, Liang RX, Qu FS, Yan TX, Sun YH, Li XQ. Zhonghua Zhong Liu Za Zhi; 2007 Jun 01; 29(6):470-3. PubMed ID: 17974287 [Abstract] [Full Text] [Related]
39. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M. Cancer; 2000 Mar 01; 88(5):988-95. PubMed ID: 10699886 [Abstract] [Full Text] [Related]
40. [In vitro thermosensitivity of various human tumors evaluated using the SDI (succinate dehydrogenase inhibition) test]. Fukuchi K, Miyamoto K. Rinsho Byori; 1990 Aug 01; 38(8):957-9. PubMed ID: 2232261 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]